Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Is treatment with emollients always beneficial?
2009-010609-35Phase 4Completed
- Sponsor
- Uppsala University
- Start
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of Canoderm, Miniderm, propylene glycol, urea and glycerol in atopic dermatitis (AD), ichthyosis vulgaris (IV) and steroid sulfatase deficiency, sponsored by Uppsala University. Primary endpoint: Change in skin barrier function after 4 weeks of emollient treatment. Started Jul 2009; status: completed.
02
Drugs
CanodermMinidermpropylene glycolureaglycerol
03
Conditions
atopic dermatitis (AD)ichthyosis vulgaris (IV)steroid sulfatase deficiency
Beyond the preview
Go deeper on 2009-010609-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010609-35.